Clinical Trials Directory

Trials / Completed

CompletedNCT03958513

To Evaluate the Effect of Wound Infiltration With Bupivacaine for Post-operative Pain Relief After Laparoscopic Cholecystectomy

Randomized, Double- Blind, Controlled Trial to Evaluate the Effect of Wound Infiltration With Bupivacaine for Post-operative Pain Relief After Laparoscopic Cholecystectomy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
58 (actual)
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To evaluate the effect of wound infiltration with 0.25% Bupivacaine in laparoscopic cholecystectomy in terms of pain severity, patient satisfaction level, quality of life, hospital stay and return to job and normal activities.

Conditions

Interventions

TypeNameDescription
DRUGBupivacaine1.5 ml 0.25% bupivacaine for 1 inch incision will be given before closure of ports in patients undergoing laparoscopic cholecystectomy
DRUG0.9% normal saline1.5 ml 0.9% NACl for 1 inch incision will be given before closure of ports in patients undergoing laparoscopic cholecystectomy

Timeline

Start date
2019-01-01
Primary completion
2019-07-31
Completion
2019-07-31
First posted
2019-05-22
Last updated
2020-06-01

Locations

1 site across 1 country: Bangladesh

Source: ClinicalTrials.gov record NCT03958513. Inclusion in this directory is not an endorsement.